领导团队

Daniela is an experienced executive leader with over 20 years Life Sciences experience in clinical research organizations, pharmaceutical companies, and academic institutions. Daniela has strong expertise in clinical development, P&L and financial management, strategy, quality and compliance management and people leadership across global regions. She is passionate about mentoring, advocacy and forging industry and academic collaborations to promote efficiencies and enhance capabilities for the clinical trial sector. Daniela holds a PhD in Chemistry from Adelaide University and is a Board Member and Deputy Chair for ARCS Australia.

Daniela Caiazza | LinkedIn

Scott oversees Clinical Services across Europe including Clinical Operations, Regulatory, Feasibility and contracting. He has more than 30 Years experience in clinical drug development across Biotech, Pharma and CROs. Prior to Joining Novotech in 2026 he was the Global Head of Early Clinical Development and EMEA Head of Therapeutic Strategy for IQVIA. Scott has also been a strategic Clinical Development Consultant for a number of MedTech, Private Equity and Healthcare companies such as Apple where he was a Strategic Health Consultant.

Scott Davis | LinkedIn

Rachael supports our global commercial organization through disciplined execution, data-driven sales operations, and scalable enablement, aligned to Novotech’s biotech-first partnership model. With over 15 years of experience across global CRO environments, she specializes in building scalable commercial infrastructure, optimizing execution, and enabling high-performing teams. Her leadership philosophy reflects our collaborative, high-touch approach: creating clarity, accountability, and operational foundations enabling teams to deliver with speed, quality, and confidence. She is passionate about empowering teams to focus on what matters most, advancing innovative therapies that improve patient lives globally.

Rachael Frazier | LinkedIn

Martin is responsible for driving the execution of the global laboratory development strategy. In this role, he focuses on enhancing operational efficiency and quality standards while orchestrating coordination and management across regional laboratories. Martin brings extensive international experience and proven commercial expertise from the global laboratory sector, leveraging his background to deliver scalable growth and operational excellence.

Martin GUAN，管一青 | LinkedIn

Elaina is a senior biopharmaceutical executive with over 20 years’ experience across biotechnology, pharmaceutical, and CROs. She has led global clinical development, operations, and strategic growth initiatives, most recently serving as Senior VP of Oncology with responsibility for global oncology portfolios and complex multinational programs. Elaina brings deep expertise across all phases of drug development, including oncology, cell and gene therapies, and radiopharmaceuticals. She is recognized for building high-performing teams, advancing innovative trial models, and aligning strategy with execution to deliver meaningful outcomes for patients and partners. 

Elaina Haeuber | LinkedIn

Raymond leads the regional Clinical Services team, including Clinical Operations and Regulatory Start-up functions. He joined Novotech in 2017 and has since played a pivotal role in building and scaling the China Clinical Operations and Project Management teams and driving the growth of the SMO business. Raymond’s career began as a Clinical Research Associate (CRA) and he went on to hold multiple leadership roles in Clinical Operations at Parexel. He further broadened his expertise at IQVIA, gaining extensive experience in portfolio and key account management.

Raymond Jia | LinkedIn

Susan’s expertise is in leading regional delivery, client engagement, and operational strategy. She joined Novotech in 2026 with more than 30 years of industry experience spanning biotech, pharma, and CRO environments, bringing a rare combination of operational rigor, commercial acumen, and people-centric leadership. Prior to Novotech, Susan held senior roles including Vice President of Clinical Operations at Syneos Health and Executive Director & Global Head of Women’s Health & Strategic Accounts. Susan is recognized for strengthening partnerships, elevating operational delivery, and guiding teams across complex global portfolios.

Susan Johnson | LinkedIn

Aditya brings over a decade of expertise to the clinical research industry, with a career spanning project management, operations, and business development within the CRO sector.

Since joining Novotech in 2018, he has served in several key leadership capacities, including Head of Business Development for the US and Europe and US Senior Director of Business Development. Before his tenure at Novotech, Aditya built a diverse foundation across clinical operations and project management. He holds a bachelor’s degree in biomedical engineering from The Johns Hopkins University and a master’s degree in medical sciences from Boston University School of Medicine.

Aditya Kotta | LinkedIn

Takeshi is leading Novotech’s Clinical and Regulatory Operations in Japan, including overseeing clinical trial conduct and managing customers. He joined Novotech in January 2026 and started to build local capabilities, strengthen partnerships with biotech clients and is continuing to develop our organization in Japan building out team on the ground there. Takeshi began his career as a CRA and brings deep pharmaceutical and CRO industry experience gained from previous multiple management positions such as Head of Japan R&D Strategy and Planning, Executive Director, Project Leadership and Director of Clinical Project Management roles at IQVIA, Parexel and BMS. 

Takeshi Mori | LinkedIn

Marina oversees Novotech’s full ECD infrastructure, leading the strategy and execution of programs that advance therapeutic assets from preclinical research through first-in-human studies, with the ultimate goal of supporting clinical proof of concept. Previously, Marina led Novotech’s global therapeutic strategy team, providing strategic oversight across Oncology, Infectious Disease, CNS, immune-mediated diseases, and ATMPs. Earlier in her career, she led pharmacy functions within a Phase I unit, including building and commissioning a GMP clean room and establishing the supporting quality system; she is a registered Pharmacist in Australia.

Marina Mullins | LinkedIn

David is responsible for data processing and analyses, with functional groups in Statistics, Programming, Data Management, and Centralized Monitoring. He joined Novotech in 2023, with prior experience in global management roles with a large global CRO as well as a China based CRO. In total, he has over 35 yrs of experience in various global roles in statistics and data management, as well as large account management. He also provides strategic and operational insight for sponsor’s clinical development strategy, assisting sponsors with study design, endpoint selection, and supporting sponsor interactions with regulatory agencies.

David Ng | LinkedIn 

Xiaoming leads Novotech’s business development strategy and commercial growth across the Asia-Pacific region. As Head of Business Development, APAC, she is responsible for strengthening strategic client relationships, driving new business opportunities, and supporting market expansion across key markets. She brings nearly 20 years of experience in the CRO industry and joined Novotech in 2017. Prior to joining Novotech, she held multiple commercial roles at IQVIA (formerly Quintiles), spanning business development, strategic account leadership, and sales leadership. 

Xiaoming Zhang | LinkedIn